- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03585790
The Impact of Soft Contact Lens Attributes on Symptoms Associated With Digital Eye Strain in Symptomatic Soft Contact Lens Wearers
December 19, 2019 updated by: Pete Kollbaum, OD, PhD
Despite its prevalence, the ocular causes of eye fatigue or unknown and may be related to the cornea/contact lens surface, the accommodative system, the convergence system, overall postural/muscle fatigue, or a combination of these or other causes.
The current study aims to systematically investigate the incremental benefits in ameliorating eye fatigue.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
Bloomington, Indiana, United States, 47405
- Indiana University Clinical Optics Research Lab
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 31 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Self-reported "eye fatigue" at least once per week attributable to digital device use with baseline.
- Uses a digital device (phone, tablet, computer, etc) at least 4 hours per day
- Mobile digital device with active data and text plan, able to receive email and text messages
- Habitual 2-week or monthly silicone single vision hydrogel soft contact lens use; habitually wearing lenses for 6 or more hours per day for 5 or more days per week for the past 30 days
- Habitual soft contact lens prescription optimized over-refraction within ±0.25 D
- 18-35 years of age
- The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
- Vertex corrected refractive cylinder must be -0.75 or less.
- Visual acuity best correctable to 20/25 or better for each eye
- The subject must read and sign the Informed Consent form.
Exclusion Criteria:
- A habitual wearer of any of the test lenses
- Any active conditions that may prevent soft contact lens wear.
- Any doctor diagnosed, self-reported ocular surface disease or dry eye requiring regular, ongoing treatment
- Any doctor diagnosed, self-reported accommodative or binocular vision issues
- History of issues of eye alignment or binocularity by self-report
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Multifocal Optics first, then Single Vision Optics
First Intervention (1 week) Second Intervention (1 week)
|
This contact lens has optics to aid the accommodative and convergence systems
This contact lens has standard single vision optics
|
|
Other: Single Vision Optics first, then Multifocal Optics
First Intervention (1 week) Second Intervention (1 week)
|
This contact lens has optics to aid the accommodative and convergence systems
This contact lens has standard single vision optics
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subject Reported Eye Fatigue
Time Frame: 1 week
|
Subjective Rating of Eye Fatigue, response to question "How would you rate your overall eye fatigue/tiredness?" on a 0-100 slider visual analog scale, where 0 represents 'Not Noticeable' and 100 represents 'Very Noticeable', with the numerical representation of their visual analog selection displayed to the right of the slider scale.
Score reported is rating as described above.
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 13, 2018
Primary Completion (Actual)
November 2, 2018
Study Completion (Actual)
November 2, 2018
Study Registration Dates
First Submitted
April 26, 2018
First Submitted That Met QC Criteria
July 2, 2018
First Posted (Actual)
July 13, 2018
Study Record Updates
Last Update Posted (Actual)
January 7, 2020
Last Update Submitted That Met QC Criteria
December 19, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Kollbaum001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
He Eye HospitalNot yet recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityActive, not recruiting
-
University Eye Hospital, FreiburgActive, not recruiting
-
University of BradfordUniversity of Huddersfield; CooperVision International Limited (CVIL)Enrolling by invitationMyopia, ProgressiveUnited Kingdom
Clinical Trials on Contact lens with Multifocal Optics
-
Alcon ResearchCompletedRefractive Error | Presbyopia | Myopia | Ametropia
-
CIBA VISIONCompleted
-
University of HoustonCompleted
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Bausch & Lomb IncorporatedCompletedPresbyopiaUnited States
-
Ohio State UniversityBausch & Lomb IncorporatedCompleted
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed